Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1998;18:1647-1654

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moore, K. J.
Right arrow Articles by Freeman, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moore, K. J.
Right arrow Articles by Freeman, M. W.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1998;18:1647-1654.)
© 1998 American Heart Association, Inc.


Original Contributions

In Vitro–Differentiated Embryonic Stem Cell Macrophages

A Model System for Studying Atherosclerosis-Associated Macrophage Functions

Kathryn J. Moore; Rosalind P. Fabunmi; Lorna P. Andersson; ; Mason W. Freeman

From the Lipid Metabolism Unit, Massachusetts General Hospital, Boston, Mass.

Correspondence to Mason W. Freeman, MD, Chief, Lipid Metabolism Unit, Massachusetts General Hospital, GRJ 1328, 55 Fruit St, Boston, MA 02114. E mail freeman@frodo.mgh.harvard.edu

Abstract—Monocytes/macrophages (Mø) appear to play a critical role in the initiation and progression of atherosclerotic lesions. In this study, we characterized in vitro–differentiated embryonic stem (ES) cell macrophages as a model system for studying atherosclerosis-associated Mø functions. Using immunofluorescence staining and Western analysis, we demonstrate that ES Mø express typical macrophage cell surface markers, as well as the known receptors for modified forms of low density lipoprotein (LDL), including the Mø scavenger receptors (SR-A type I and type II), CD36, and CD68. Differentiated ES Mø specifically bind and degrade 125I-labeled acetylated LDL with high affinity, and their incubation with acetylated LDL (15 µg/mL) for 48 hours produces characteristic "foamy" Mø, as visualized by oil red O staining. ES Mø also express matrix-degrading metalloproteinases (MMP-3, MMP-9), which have been implicated in collagen breakdown in the fibrous cap of atherosclerotic plaques, and secrete cytokines (tumor necrosis factor-{alpha}, interleukin-6) in response to inflammatory stimuli. Transfection experiments, using a green fluorescent protein reporter gene, driven by the myeloid-specific promoter, CD11b, demonstrated that ES Mø can also be used to study macrophage-restricted gene expression in vitro. Taken together, these data demonstrate that ES Mø exhibit many properties typical of arterial lesion macrophages. Its ease of genetic manipulation makes it an attractive system for investigations of macrophage functions in vitro.


Key Words: atherosclerosis • macrophage • scavenger receptor • foam cell




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
J. I. Odegaard, D. Vats, L. Zhang, R. Ricardo-Gonzalez, K. L. Smith, D. B. Sykes, M. P. Kamps, and A. Chawla
Quantitative expansion of ES cell-derived myeloid progenitors capable of differentiating into macrophages
J. Leukoc. Biol., March 1, 2007; 81(3): 711 - 719.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. L. Olsen, D. L. Stachura, and M. J. Weiss
Designer blood: creating hematopoietic lineages from embryonic stem cells
Blood, February 15, 2006; 107(4): 1265 - 1275.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Majdalawieh, L. Zhang, I. V. Fuki, D. J. Rader, and H.-S. Ro
Adipocyte enhancer-binding protein 1 is a potential novel atherogenic factor involved in macrophage cholesterol homeostasis and inflammation
PNAS, February 14, 2006; 103(7): 2346 - 2351.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
A.-L. Bolcato-Bellemin, M.-G. Mattei, M. Fenton, and S. Amar
Molecular cloning and characterization of mouse LITAF cDNA: role in the regulation of tumor necrosis factor-{alpha} (TNF-{alpha}) gene expression
Innate Immunity, February 1, 2004; 10(1): 15 - 23.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
V. V. Kunjathoor, M. Febbraio, E. A. Podrez, K. J. Moore, L. Andersson, S. Koehn, J. S. Rhee, R. Silverstein, H. F. Hoff, and M. W. Freeman
Scavenger Receptors Class A-I/II and CD36 Are the Principal Receptors Responsible for the Uptake of Modified Low Density Lipoprotein Leading to Lipid Loading in Macrophages
J. Biol. Chem., December 13, 2002; 277(51): 49982 - 49988.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Biwa, M. Sakai, T. Matsumura, S. Kobori, K. Kaneko, A. Miyazaki, H. Hakamata, S. Horiuchi, and M. Shichiri
Sites of Action of Protein Kinase C and Phosphatidylinositol 3-Kinase Are Distinct in Oxidized Low Density Lipoprotein-induced Macrophage Proliferation
J. Biol. Chem., February 25, 2000; 275(8): 5810 - 5816.
[Abstract] [Full Text] [PDF]